Fri, December 11, 2020
Thu, December 10, 2020
Wed, December 9, 2020

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Increased Target to $64 on, Dec 10th, 2020

Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $53 to $64 on, Dec 10th, 2020.

Raghuram has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $44 on, Friday, December 4th, 2020